| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Apoptosis pathways in cancer and cancer therapy
|
Debatin, Klaus-Michael
|
|
2004
|
53 |
3 |
p. 153-159
|
artikel
|
| 2 |
A primer on cancer immunology and immunotherapy
|
Lotze, Michael T.
|
|
2004
|
53 |
3 |
p. 135-138
|
artikel
|
| 3 |
Dendritic cell biology and cancer therapy
|
Whiteside, Theresa L.
|
|
2004
|
53 |
3 |
p. 240-248
|
artikel
|
| 4 |
Exosome-based immunotherapy
|
Chaput, Nathalie
|
|
2004
|
53 |
3 |
p. 234-239
|
artikel
|
| 5 |
Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer
|
Castelli, Chiara
|
|
2004
|
53 |
3 |
p. 227-233
|
artikel
|
| 6 |
Identification of tumor antigens and T-cell epitopes, and its clinical application
|
Paschen, Annette
|
|
2004
|
53 |
3 |
p. 196-203
|
artikel
|
| 7 |
Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning
|
Jäger, Dirk
|
|
2004
|
53 |
3 |
p. 144-147
|
artikel
|
| 8 |
Identification of tumour antigens by serological analysis of cDNA expression cloning
|
Li, Geng
|
|
2004
|
53 |
3 |
p. 139-143
|
artikel
|
| 9 |
Identification of tumour antigens by serological analysis of cDNA expression cloning
|
Li, Geng
|
|
|
53 |
3 |
p. 139-143
|
artikel
|
| 10 |
Identifying biomarkers and surrogates of tumors (cancer biometrics): correlation with immunotherapies and immune cells
|
Lotze, Michael T.
|
|
2004
|
53 |
3 |
p. 256-261
|
artikel
|
| 11 |
Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy
|
Baxevanis, Constantin N.
|
|
2004
|
53 |
3 |
p. 166-175
|
artikel
|
| 12 |
Immunological inhibition of carcinogenesis
|
Spadaro, Michela
|
|
2004
|
53 |
3 |
p. 204-216
|
artikel
|
| 13 |
Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination
|
Romero, Pedro
|
|
2004
|
53 |
3 |
p. 249-255
|
artikel
|
| 14 |
Natural killer lymphocytes: biology, development, and function
|
Papamichail, Michael
|
|
2004
|
53 |
3 |
p. 176-186
|
artikel
|
| 15 |
Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors
|
Wels, Winfried
|
|
2004
|
53 |
3 |
p. 217-226
|
artikel
|
| 16 |
Tetraspanins connect several types of Ig proteins: IgM is a novel component of the tetraspanin web on B-lymphoid cells
|
Naour, François Le
|
|
2004
|
53 |
3 |
p. 148-152
|
artikel
|
| 17 |
The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy
|
Singh-Jasuja, Harpreet
|
|
2004
|
53 |
3 |
p. 187-195
|
artikel
|
| 18 |
The use of gene function to identify the rate-limiting steps controlling cell fate
|
Williams, Gwyn T.
|
|
2004
|
53 |
3 |
p. 160-165
|
artikel
|
| 19 |
Tumour escape: antitumour effectors too much of a good thing?
|
Pawelec, Graham
|
|
2004
|
53 |
3 |
p. 262-274
|
artikel
|
Tijdschrift beschrijving